0001882178-21-000020.txt : 20211007
0001882178-21-000020.hdr.sgml : 20211007
20211007200530
ACCESSION NUMBER: 0001882178-21-000020
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211007
FILED AS OF DATE: 20211007
DATE AS OF CHANGE: 20211007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ricciardi Lisa
CENTRAL INDEX KEY: 0001418200
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40886
FILM NUMBER: 211313544
MAIL ADDRESS:
STREET 1: C/O COGNITION THERAPEUTICS, INC
STREET 2: 2500 WESTCHESTER AVENUE
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001455365
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 2403 SIDNEY STREET
STREET 2: SUITE 261
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: 412-481-2210
MAIL ADDRESS:
STREET 1: 2500 WESTCHESTER AVE
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: COGNITION THERAPUTICS INC
DATE OF NAME CHANGE: 20090204
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2021-10-07
0
0001455365
COGNITION THERAPEUTICS INC
CGTX
0001418200
Ricciardi Lisa
C/O COGNITION THERAPEUTICS, INC.,
2500 WESTCHESTER AVE.,
PURCHASE,
NY
10577
1
1
0
0
CEO & President
Stock Option (right to buy)
1.07
2029-09-29
Common Stock
20095
D
Stock Option (right to buy)
1.07
2030-02-27
Common Stock
7729
D
Stock Option (right to buy)
1.2
2030-06-01
Common Stock
896177
D
Stock Option (right to buy)
1.2
2030-03-23
Common Stock
41737
D
The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on September 29, 2019.
The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on February 27, 2020.
25% of the shares underlying the option vest on the first anniversary of the option's grant date and the remaining 75% vest in equal monthly installments for the thirty-six (36) months thereafter. The option was granted on June 1, 2020.
The option is fully vested.
/s/ Lisa Ricciardi, Attorney-in-Fact
2021-10-07